Lyme disease history and symptoms: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(17 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Lyme disease}}
{{Lyme disease}}
{{CMG}} {{AE}}{{Anmol}}, {{IMD}}
{{CMG}};{{AE}}{{Anmol}}, {{IMD}}
==Overview==
==Overview==
[[Lyme disease]] is divided into 3 stages and symptoms are stage specific. Initial symptoms include "bulls-eye" [[rash]], with accompanying flu-like symptoms. It can progress to [[cardiovascular]] or [[neurological]] complications.
[[Lyme disease]] is divided into 3 stages and the symptoms are stage specific. Initial symptoms include bullseye [[rash]] called [[erythema migrans]], with accompanying flu-like symptoms. Lyme disease can progress to [[cardiovascular]], [[neurological]], [[dermatological]] and/or [[musculoskeletal]] manifestations. Multiple [[erythema migrans]] develops as [[Disseminated disease|disease disseminates]] throughout the body. Most common [[neurological]] manifestation includes [[lymphocytic]] [[meningitis]] and [[cranial nerve palsies]] (usually [[facial nerve palsy]]). Dermatological manifestation includes borrelial lymphocytoma and [[acrodermatitis chronica atrophicans]] appearing in [[Lyme disease history and symptoms#Symptoms|stage 2]] and [[Lyme disease history and symptoms#Symptoms|stage 3 Lyme disease]] respectively. [[Cardiac]] manifestation include [[Lyme carditis]]. [[Musculoskeletal]] manifestation include [[Lyme arthritis]]. There is a difference in clinical features of [[Lyme disease]] in patients living in different geographical regions depending on the genospecies of [[Borrelia burgdorferi]] sensu lato complex causing it.


==History==
==History==
*The [[incubation period]] from [[infection]] to the onset of symptoms is usually 1&ndash;2 weeks, but can be much shorter (days), or much longer (months to years). Symptoms most often occur from May through September because the nymphal stage of the [[tick]] is responsible for most cases. <ref name="pmid10206627">{{cite journal| author=Falco RC, McKenna DF, Daniels TJ, Nadelman RB, Nowakowski J, Fish D et al.| title=Temporal relation between Ixodes scapularis abundance and risk for Lyme disease associated with erythema migrans. | journal=Am J Epidemiol | year= 1999 | volume= 149 | issue= 8 | pages= 771-6 | pmid=10206627 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10206627  }}</ref>[[Asymptomatic]] [[infection]] exists, but is uncommon.<ref name="pmid12905137">{{cite journal |author=Steere AC, Sikand VK, Schoen RT, Nowakowski J |title=Asymptomatic infection with Borrelia burgdorferi |journal=Clin. Infect. Dis. |volume=37 |issue=4 |pages=528-32 |year=2003 |pmid=12905137}}</ref>
*The [[incubation period]] from [[infection]] to the onset of symptoms is usually 1&ndash;2 weeks, but can be much shorter (days), or much longer (months to years). Symptoms most often occur from May through September because the nymphal stage of the [[tick]] is responsible for most cases.<ref name="pmid10206627">{{cite journal| author=Falco RC, McKenna DF, Daniels TJ, Nadelman RB, Nowakowski J, Fish D et al.| title=Temporal relation between Ixodes scapularis abundance and risk for Lyme disease associated with erythema migrans. | journal=Am J Epidemiol | year= 1999 | volume= 149 | issue= 8 | pages= 771-6 | pmid=10206627 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10206627  }}</ref> [[Asymptomatic]] [[infection]] can happen, but is uncommon.<ref name="pmid12905137">{{cite journal |author=Steere AC, Sikand VK, Schoen RT, Nowakowski J |title=Asymptomatic infection with Borrelia burgdorferi |journal=Clin. Infect. Dis. |volume=37 |issue=4 |pages=528-32 |year=2003 |pmid=12905137}}</ref>
*The specific areas of focus when obtaining the history, are outlined below:
*The specific areas of focus when obtaining patient history are outlined below:
** [[Tick]] bite
** [[Tick]] bite
** Vacation, living, or working environment in [[Endemic (epidemiology)|endemic]] areas
** Vacation, living, or working environment in [[Endemic (epidemiology)|endemic]] areas
**Spending time outdoor (especially in woody or grassy area).
**Spending time outdoors (especially in woody or grassy areas)


==Symptoms==
==Symptoms==
[[Lyme disease]] is divided into 3 stages and symptoms are stage specific.
[[Lyme disease]] is divided into 3 stages and symptoms are stage specific.
#Stage 1 - Early localized disease
*Stage 1 - Early localized disease
#Stage 2 - Early disseminated disease
*Stage 2 - Early disseminated disease
#Stage 3 - Late disseminated disease
*Stage 3 - Late disseminated disease


===Stage 1 - Early localized disease===
===Stage 1 - Early localized disease===
Line 22: Line 22:
|
|
Features of early localized disease includes [[erythema migrans]] and flu-like symptoms.
Features of early localized disease includes [[erythema migrans]] and flu-like symptoms.
*'''[[Erythema migrans]] (EM)''' also known as [[erythema chronicum migrans]], "bull’s-eye" rash, or [[Lyme]] rash develops in around 70% - 80% of patients.<ref name="pmid12802042">{{cite journal| author=Steere AC, Sikand VK| title=The presenting manifestations of Lyme disease and the outcomes of treatment. | journal=N Engl J Med | year= 2003 | volume= 348 | issue= 24 | pages= 2472-4 | pmid=12802042 | doi=10.1056/NEJM200306123482423 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12802042  }} </ref>
*'''[[Erythema migrans]] (EM)''' also known as [[erythema chronicum migrans]], bullseye rash, or [[Lyme]] rash develops in around 70% - 80% of patients.<ref name="pmid12802042">{{cite journal| author=Steere AC, Sikand VK| title=The presenting manifestations of Lyme disease and the outcomes of treatment. | journal=N Engl J Med | year= 2003 | volume= 348 | issue= 24 | pages= 2472-4 | pmid=12802042 | doi=10.1056/NEJM200306123482423 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12802042  }} </ref>
**EM begins at the site of a [[tick]] bite after a delay of 3 to 30 days (average is about 7 days).
**EM begins at the site of a [[tick]] bite after a delay of 3 to 30 days (average is about 7 days).
**EM gradually expands over a period of days reaching up to 12 inches(30 cm)or more across.
**EM gradually expands over a period of days reaching up to 12 inches (30 cm) or more across.
**EM may feel warm to touch but is rarely [[Itch|itchy]] or [[Pain|painful]].
**EM may feel warm to touch but is rarely [[Itch|itchy]] or [[Pain|painful]].
**EM clears as it enlarges, resulting in a target or “bull’s-eye” appearance.
**EM clears as it enlarges, resulting in a target or bullseye appearance.
**EM may appear on any area of the body but majority of times present in areas including [[axilla]], [[inguinal region]], [[popliteal fossa]], or along belt line.
**EM may appear on any area of the body but is usually present on areas including the [[axilla]], [[inguinal region]], [[popliteal fossa]], or along the belt line.
**The [[rash]] does not represent an [[allergic reaction]] to the bite, but rather a [[skin infection]] with the [[Borrelia burgdorferi|Lyme bacteria]], [[Lyme disease microbiology|''Borrelia burgdorferi'' sensu lato]].
**The [[rash]] does not represent an [[allergic reaction]] to the bite, but rather a [[skin infection]] with the [[Borrelia burgdorferi|Lyme bacteria]], [[Lyme disease microbiology|''Borrelia burgdorferi'' sensu lato]].
**An [[infection]] resulting from a [[Borrelia mayonii|B. mayonii]] [[infection]] may cause a diffuse [[rash]], erupting in "red spots," spanning the entire [[body]].
**An [[infection]] resulting from a ''[[Borrelia mayonii|B. mayonii]]'' [[infection]] may cause a diffuse [[rash]] erupting in red spots, spanning the entire [[body]].
*Flu-like symptoms including:<ref name="pmid8644761">{{cite journal| author=Nadelman RB, Nowakowski J, Forseter G, Goldberg NS, Bittker S, Cooper D et al.| title=The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. | journal=Am J Med | year= 1996 | volume= 100 | issue= 5 | pages= 502-8 | pmid=8644761 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8644761  }} </ref>
*Flu-like symptoms including:<ref name="pmid8644761">{{cite journal| author=Nadelman RB, Nowakowski J, Forseter G, Goldberg NS, Bittker S, Cooper D et al.| title=The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. | journal=Am J Med | year= 1996 | volume= 100 | issue= 5 | pages= 502-8 | pmid=8644761 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8644761  }} </ref>
**[[Fatigue]]
**[[Fatigue]]
Line 39: Line 39:
**[[Anorexia]]
**[[Anorexia]]
|
|
[[Image:Classic Lyme disease rash.jpg|thumb|250px|center|[https://www.cdc.gov/lyme/signs_symptoms/rashes.html Classic Lyme disease rash, Source:CDC]]]
[[Image:Classic Lyme disease rash.jpg|thumb|250px|center|Classic Lyme disease rash - [https://www.cdc.gov/lyme/signs_symptoms/rashes.html Source: CDC.gov]]]


[[Image:Lyme disease Expanding rash with central crust.jpg|thumb|250px|center|[https://www.cdc.gov/lyme/signs_symptoms/rashes.html Lyme disease, expanding rash with central clearing, Source:CDC]]]
[[Image:Lyme disease Expanding rash with central crust.jpg|thumb|250px|center|Lyme disease, expanding rash with central clearing - [https://www.cdc.gov/lyme/signs_symptoms/rashes.html Source: CDC.gov]]]
|}
|}


Line 47: Line 47:
{|
{|
|
|
Features of early disseminated disease can be divided system wise and includes:
Features of early disseminated disease can be divided by organ system and include:
*Multiple [[erythema migrans]]<ref name="pmid158674072">{{cite journal| author=Wormser GP, McKenna D, Carlin J, Nadelman RB, Cavaliere LF, Holmgren D et al.| title=Brief communication: hematogenous dissemination in early Lyme disease. | journal=Ann Intern Med | year= 2005 | volume= 142 | issue= 9 | pages= 751-5 | pmid=15867407 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15867407  }}</ref>
*Multiple [[erythema migrans]]<ref name="pmid158674072">{{cite journal| author=Wormser GP, McKenna D, Carlin J, Nadelman RB, Cavaliere LF, Holmgren D et al.| title=Brief communication: hematogenous dissemination in early Lyme disease. | journal=Ann Intern Med | year= 2005 | volume= 142 | issue= 9 | pages= 751-5 | pmid=15867407 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15867407  }}</ref>
*Neurological symptoms: The triad of [[Neurological|neurologic]] manifestation of [[Lyme disease]] includes [[meningitis]], [[cranial]] [[neuritis]], and radiculoneuritis.<ref name="pmid184528002">{{cite journal|author=Halperin JJ|title=Nervous system Lyme disease.|journal=Infect Dis Clin North Am|year=2008|volume=22|issue=2|pages=261-74, vi|pmid=18452800|doi=10.1016/j.idc.2007.12.009|pmc=|url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18452800}}</ref>
*Neurological symptoms: The triad of [[Neurological|neurologic]] manifestation of [[Lyme disease]] includes [[meningitis]], [[cranial]] [[neuritis]], and radiculoneuritis.<ref name="pmid184528002">{{cite journal|author=Halperin JJ|title=Nervous system Lyme disease.|journal=Infect Dis Clin North Am|year=2008|volume=22|issue=2|pages=261-74, vi|pmid=18452800|doi=10.1016/j.idc.2007.12.009|pmc=|url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18452800}}</ref>
Line 60: Line 60:
**[[Cerebellar ataxia]]
**[[Cerebellar ataxia]]
|
|
[[Image:LymeMultiple rash, disseminated infection.jpg|thumb|250px|right|[https://www.cdc.gov/lyme/signs_symptoms/rashes.html Disseminated Lyme disease, multiple rash, Source:CDC]]]
[[Image:LymeMultiple rash, disseminated infection.jpg|thumb|250px|right| Disseminated Lyme disease, multiple rash - [https://www.cdc.gov/lyme/signs_symptoms/rashes.html Source: CDC.gov]]]
|}
|}
*[[Cardiac]] manifestations
*[[Cardiac]] manifestations
Line 69: Line 69:
**Chronic [[cardiomyopathy]]
**Chronic [[cardiomyopathy]]
*[[Dermatological]] manifestations<ref name="pmid15358567">{{cite journal| author=Mullegger RR| title=Dermatological manifestations of Lyme borreliosis. | journal=Eur J Dermatol | year= 2004 | volume= 14 | issue= 5 | pages= 296-309 | pmid=15358567 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15358567  }} </ref>
*[[Dermatological]] manifestations<ref name="pmid15358567">{{cite journal| author=Mullegger RR| title=Dermatological manifestations of Lyme borreliosis. | journal=Eur J Dermatol | year= 2004 | volume= 14 | issue= 5 | pages= 296-309 | pmid=15358567 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15358567  }} </ref>
**Borrelial lymphocytoma: Most common site is [[earlobe]].
**Borrelial lymphocytoma: most common site is [[earlobe]]
*[[Ocular]] manifestations<ref name="pmid14630446">{{cite journal| author=Stanek G, Strle F| title=Lyme borreliosis. | journal=Lancet | year= 2003 | volume= 362 | issue= 9396 | pages= 1639-47 | pmid=14630446 | doi=10.1016/S0140-6736(03)14798-8 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14630446  }}</ref>
*[[Ocular]] manifestations<ref name="pmid14630446">{{cite journal| author=Stanek G, Strle F| title=Lyme borreliosis. | journal=Lancet | year= 2003 | volume= 362 | issue= 9396 | pages= 1639-47 | pmid=14630446 | doi=10.1016/S0140-6736(03)14798-8 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14630446  }}</ref>
**Primary [[ocular]] symptoms occurs due to [[inflammation]] of [[ocular]] tissue. These symptoms includes [[conjunctivitis]], [[keratitis]], [[iridocyclitis]], [[retinal]] [[vasculitis]], chorioiditis, and [[optic neuropathy]] (extremely rarely [[episcleritis]], panuveitis, panophthalmitis).
**Primary [[ocular]] symptoms occur due to [[inflammation]] of [[ocular]] tissue. These symptoms include [[conjunctivitis]], [[keratitis]], [[iridocyclitis]], [[retinal]] [[vasculitis]], chorioiditis, and [[optic neuropathy]] (and, extremely rarely, [[episcleritis]], panuveitis, panophthalmitis).
**Secondary [[ocular]] symptoms occurs due to extraocular manifestations. These symptoms includes [[Cranial nerve palsies|pareses of cranial nerves]] and [[Orbit (anatomy)|orbital]] [[myositis]].
**Secondary [[ocular]] symptoms occur due to extraocular manifestations. These symptoms includes [[Cranial nerve palsies|pareses of cranial nerves]] and [[Orbit (anatomy)|orbital]] [[myositis]].


===Stage 3 - Late disseminated disease===
===Stage 3 - Late disseminated disease===
*Features of late disseminated disease can take months to years to manifest after the onset of [[infection]].
*Features of late disseminated disease can take months to years to manifest after the onset of [[infection]].
*[[Lyme arthritis]] is dominant months later but chronic [[neurologic]] involvement becomes more obvious years later.
*[[Lyme arthritis]] is dominant months later but chronic [[neurologic]] involvement becomes more obvious years later.
* The symptoms of late [[Disseminated disease|disseminated]] lyme disease includes:
* The symptoms of late [[Disseminated disease|disseminated]] Lyme disease include:
**[[Musculoskeletal]] manifestation:
**[[Musculoskeletal]] manifestations:
***[[Lyme arthritis]]
***[[Lyme arthritis]]
****[[Lyme arthritis]] is the hallmark of stage 3 [[Lyme disease]].
****[[Lyme arthritis]] is the hallmark of stage 3 [[Lyme disease]].
Line 84: Line 84:
****Commonly affects [[Knee|knee joint]].
****Commonly affects [[Knee|knee joint]].
**[[Neurology|Neurological]] manifestations:  
**[[Neurology|Neurological]] manifestations:  
***These [[neurological]] symptoms may take months to years to manifest after the [[infection]]. In addition to acute symptoms, Neuroborrerliosis can be manifested by a wide-range of [[Neurology|neurological]] disorders, either [[Central nervous system|central]] or [[Peripheral nervous system|peripheral]] including:
***These [[neurological]] symptoms may take months to years to manifest after the [[infection]]. In addition to acute symptoms, neuroborreliosis can manifest as a wide-range of [[Neurology|neurological]] disorders, either [[Central nervous system|central]] or [[Peripheral nervous system|peripheral]] including:
**** [[Encephalopathy]] (sub-acute): Affects  [[memory]], [[Mood (psychology)|mood]], [[sleep]], and sometimes with subtle [[language]] disturbances.
**** [[Encephalopathy]] (sub-acute): Affects  [[memory]], [[Mood (psychology)|mood]], [[sleep]], and sometimes with subtle [[language]] disturbances
**** [[Polyneuropathy]] or [[Paresthesia]]
**** [[Polyneuropathy]] or [[paresthesia]]
**** Leukoencephalitis<ref name="pmid192279822">{{cite journal|year=1991|title=Central nervous system abnormalities in Lyme neuroborreliosis.|url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1922798|journal=Neurology|volume=41|issue=10|pages=1571-82|doi=|pmc=|pmid=1922798|author=Halperin JJ, Volkman DJ, Wu P}}</ref>
**** Leukoencephalitis<ref name="pmid192279822">{{cite journal|year=1991|title=Central nervous system abnormalities in Lyme neuroborreliosis.|url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1922798|journal=Neurology|volume=41|issue=10|pages=1571-82|doi=|pmc=|pmid=1922798|author=Halperin JJ, Volkman DJ, Wu P}}</ref>
**** [[Fasciculation|Muscle twitching]]
**** [[Fasciculation|Muscle twitching]]
**** [[Otolaryngology|Otolaryngologic]] manifestations: [[Neck pain]], [[odynophagia]], head and neck [[dysesthesia]], [[otalgia]], [[tinnitus]], [[hearing loss]], [[vertigo]], [[temporomandibular joint pain]], [[lymphadenopathy]], [[dysgeusia]].<ref>{{cite journal|year=1988|title=Borrelia infection and vertigo|journal=Acta Otolaryngol.|volume=106|issue=1-2|pages=111-6|pmid=3421091|author=Rosenhall U, Hanner P, Kaijser B}}</ref><ref>{{cite journal|author=Moscatello AL, Worden DL, Nadelman RB, Wormser G, Lucente F|title=Otolaryngologic aspects of Lyme disease|journal=Laryngoscope|volume=101|issue=6 Pt 1|pages=592-5|year=1991|pmid=2041438}}</ref>
**** [[Otolaryngology|Otolaryngologic]] manifestations: [[Neck pain]], [[odynophagia]], head and neck [[dysesthesia]], [[otalgia]], [[tinnitus]], [[hearing loss]], [[vertigo]], [[temporomandibular joint pain]], [[lymphadenopathy]], and [[dysgeusia]]<ref>{{cite journal|year=1988|title=Borrelia infection and vertigo|journal=Acta Otolaryngol.|volume=106|issue=1-2|pages=111-6|pmid=3421091|author=Rosenhall U, Hanner P, Kaijser B}}</ref><ref>{{cite journal|author=Moscatello AL, Worden DL, Nadelman RB, Wormser G, Lucente F|title=Otolaryngologic aspects of Lyme disease|journal=Laryngoscope|volume=101|issue=6 Pt 1|pages=592-5|year=1991|pmid=2041438}}</ref>
***[[Neuropsychiatric]] symptoms often develop much later in the disease progression, much like tertiary [[neurosyphilis]].<ref name="LogigianKaplan1990">{{cite journal|last1=Logigian|first1=Eric L.|last2=Kaplan|first2=Richard F.|last3=Steere|first3=Allen C.|title=Chronic Neurologic Manifestations of Lyme Disease|journal=New England Journal of Medicine|volume=323|issue=21|year=1990|pages=1438–1444|issn=0028-4793|doi=10.1056/NEJM199011223232102}}</ref>
***[[Neuropsychiatric]] symptoms often develop much later in the disease's progression, much like tertiary [[neurosyphilis]]<ref name="LogigianKaplan1990">{{cite journal|last1=Logigian|first1=Eric L.|last2=Kaplan|first2=Richard F.|last3=Steere|first3=Allen C.|title=Chronic Neurologic Manifestations of Lyme Disease|journal=New England Journal of Medicine|volume=323|issue=21|year=1990|pages=1438–1444|issn=0028-4793|doi=10.1056/NEJM199011223232102}}</ref>
*** In rare cases, frank [[psychosis]] have been attributed to chronic [[Lyme disease]] effects, including misdiagnoses of [[schizophrenia]] and [[bipolar disorder]].
*** In rare cases, frank [[psychosis|psychoses]] have been attributed to chronic [[Lyme disease]] effects, including misdiagnoses of [[schizophrenia]] and [[bipolar disorder]]
*** [[Panic attack]] and [[anxiety]] can occur, also [[delusional]] [[behavior]], including somatoform [[delusions]], sometimes accompanied by a [[depersonalization]] or [[derealization]] syndrome similar to what was seen in the past in the prodromal or early stages of general [[paresis]].<ref>{{cite journal|year=1994|title=Lyme disease: a neuropsychiatric illness|journal=The American journal of psychiatry|volume=151|issue=11|pages=1571-83|pmid=7943444|author=Fallon BA, Nields JA}}{{cite journal|author=Hess A, Buchmann J, Zettl UK, ''et al''|title=Borrelia burgdorferi central nervous system infection presenting as an organic schizophrenialike disorder|journal=Biol. Psychiatry|volume=45|issue=6|pages=795|year=1999|pmid=10188012}})</ref>
*** [[Panic attack]] and [[anxiety]] can occur, as well as [[delusional]] [[behavior]], including somatoform [[delusions]] sometimes accompanied by a [[depersonalization]] or [[derealization]] syndrome similar to what was seen in the past in the prodromal or early stages of general [[paresis]]<ref>{{cite journal|year=1994|title=Lyme disease: a neuropsychiatric illness|journal=The American journal of psychiatry|volume=151|issue=11|pages=1571-83|pmid=7943444|author=Fallon BA, Nields JA}}{{cite journal|author=Hess A, Buchmann J, Zettl UK, ''et al''|title=Borrelia burgdorferi central nervous system infection presenting as an organic schizophrenialike disorder|journal=Biol. Psychiatry|volume=45|issue=6|pages=795|year=1999|pmid=10188012}})</ref>
**[[Dermatological]] manifestation<ref name="pmid15358567">{{cite journal| author=Mullegger RR| title=Dermatological manifestations of Lyme borreliosis. | journal=Eur J Dermatol | year= 2004 | volume= 14 | issue= 5 | pages= 296-309 | pmid=15358567 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15358567  }} </ref>
**[[Dermatological]] manifestations:<ref name="pmid15358567">{{cite journal| author=Mullegger RR| title=Dermatological manifestations of Lyme borreliosis. | journal=Eur J Dermatol | year= 2004 | volume= 14 | issue= 5 | pages= 296-309 | pmid=15358567 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15358567  }} </ref>
***[[Acrodermatitis chronica atrophicans]]
***[[Acrodermatitis chronica atrophicans]]


Line 99: Line 99:
|
|
{|
{|
! style="width: 80px; background: #4479BA; text-align: center;" colspan="2" |{{fontcolor|#FFF||Symptoms differentiated on the basis of frequency}}
! colspan="2" style="width: 80px; background: #4479BA; text-align: center;" |{{fontcolor|#FFF||Symptoms differentiated on the basis of frequency}}
<ref name="Ciesielski_198922">{{cite journal|year=1989|title=Lyme disease surveillance in the United States, 1983-1986|journal=Rev. Infect. Dis.|volume=11 Suppl 6|issue=|pages=S1435-41|pmid=2682955|author=Ciesielski CA, Markowitz LE, Horsley R, Hightower AW, Russell H, Broome CV}}</ref>
<ref name="Ciesielski_198922">{{cite journal|year=1989|title=Lyme disease surveillance in the United States, 1983-1986|journal=Rev. Infect. Dis.|volume=11 Suppl 6|issue=|pages=S1435-41|pmid=2682955|author=Ciesielski CA, Markowitz LE, Horsley R, Hightower AW, Russell H, Broome CV}}</ref>
|-
|-
Line 117: Line 117:


*[[Lyme arthritis]]
*[[Lyme arthritis]]
*[[Neurological]] manifestation
*[[Neurological]] manifestations
| style="background: #DCDCDC; padding: 5px; " |
| style="background: #DCDCDC; padding: 5px; " |
*[[Cardiac]] manifestations
*[[Cardiac]] manifestations
Line 128: Line 128:


{|
{|
! style="width: 80px; background: #4479BA; text-align: center;" colspan="3" |{{fontcolor|#FFF||Difference in clinical features in Europe and North America}}<ref name="pmid18452805">{{cite journal| author=Stanek G, Strle F| title=Lyme disease: European perspective. | journal=Infect Dis Clin North Am | year= 2008 | volume= 22 | issue= 2 | pages= 327-39, vii | pmid=18452805 | doi=10.1016/j.idc.2008.01.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18452805  }}</ref>
! colspan="3" style="width: 80px; background: #4479BA; text-align: center;" |{{fontcolor|#FFF||Difference in clinical features in Europe and North America}}<ref name="pmid18452805">{{cite journal| author=Stanek G, Strle F| title=Lyme disease: European perspective. | journal=Infect Dis Clin North Am | year= 2008 | volume= 22 | issue= 2 | pages= 327-39, vii | pmid=18452805 | doi=10.1016/j.idc.2008.01.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18452805  }}</ref>
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;" | '''Features'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" | '''Features'''
Line 135: Line 135:
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;" | [[Erythema migrans]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" | [[Erythema migrans]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Single lesion more frequently
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Single [[lesion]] more frequently
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Multiple lesions occurs more freuqently
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Multiple [[lesions]] occurs more freuqently
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;" | Heterogenous [[Disseminated disease|dissemination]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" | Heterogenous [[Disseminated disease|dissemination]]
Line 162: Line 162:
{|
{|
|
|
*'''[[Erythema migrans]] (EM)''' also known as [[erythema chronicum migrans]], "bull’s-eye" rash, or [[Lyme]] rash develops in around 70% - 80% of patients.<ref name="pmid12802042">{{cite journal| author=Steere AC, Sikand VK| title=The presenting manifestations of Lyme disease and the outcomes of treatment. | journal=N Engl J Med | year= 2003 | volume= 348 | issue= 24 | pages= 2472-4 | pmid=12802042 | doi=10.1056/NEJM200306123482423 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12802042  }} </ref>
*'''[[Erythema migrans]] (EM)''', also known as [[erythema chronicum migrans]], bullseye rash, or [[Lyme]] rash, develops in around 70% - 80% of patients.<ref name="pmid12802042">{{cite journal| author=Steere AC, Sikand VK| title=The presenting manifestations of Lyme disease and the outcomes of treatment. | journal=N Engl J Med | year= 2003 | volume= 348 | issue= 24 | pages= 2472-4 | pmid=12802042 | doi=10.1056/NEJM200306123482423 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12802042  }} </ref>
**EM is the the pathognomonic [[rash]] of [[Lyme disease]]. Majority of patients with the [[rash]] do not recall tick bite.
**EM is the [[pathognomonic]] [[rash]] of [[Lyme disease]]. The majority of patients with the [[rash]] do not recall a tick bite.
**EM begins at the site of a [[tick]] bite after a delay of 3 to 30 days (average is about 7 days).
**EM begins at the site of a [[tick]] bite after a delay of 3 to 30 days (average is about 7 days).
**EM is classically 5 to 6.8 cm in diameter appearing as an annular homogenous [[erythema]] (59%), central [[erythema]] (30%), central clearing (9%), or central [[purpura]] (2%).<ref name="pmid17113969">{{cite journal| author=Feder HM, Abeles M, Bernstein M, Whitaker-Worth D, Grant-Kels JM| title=Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis. | journal=Clin Dermatol | year= 2006 | volume= 24 | issue= 6 | pages= 509-20 | pmid=17113969 | doi=10.1016/j.clindermatol.2006.07.012 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17113969  }} </ref>
**EM is classically 5 to 6.8 cm in diameter and appears as an annular homogenous [[erythema]] (59%), central [[erythema]] (30%), central clearing (9%), or central [[purpura]] (2%).<ref name="pmid17113969">{{cite journal| author=Feder HM, Abeles M, Bernstein M, Whitaker-Worth D, Grant-Kels JM| title=Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis. | journal=Clin Dermatol | year= 2006 | volume= 24 | issue= 6 | pages= 509-20 | pmid=17113969 | doi=10.1016/j.clindermatol.2006.07.012 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17113969  }} </ref>
**EM gradually expands over a period of days reaching up to 12 inches (30 cm) or more across.
**EM gradually expands over a period of days reaching up to 12 inches (30 cm) or more across.
**EM may feel warm to touch but is rarely [[Itch|itchy]] or [[Pain|painful]].
**EM may feel warm to touch but is rarely [[Itch|itchy]] or [[Pain|painful]].
**EM clears as it enlarges, resulting in a target or “bull’s-eye” appearance.
**EM clears as it enlarges, resulting in a target or bullseye appearance.
**EM may appear on any area of the body but majority of times present in areas including [[axilla]], [[inguinal region]], or [[popliteal fossa]].
**EM may appear on any area of the body but is usually present in areas including the [[axilla]], [[inguinal region]], or [[popliteal fossa]].
**The [[rash]] does not represent an [[allergic reaction]] to the bite, but rather a [[skin infection]] with the [[Borrelia burgdorferi|Lyme bacteria]], [[Lyme disease microbiology|''Borrelia burgdorferi'' sensu lato]].
**The [[rash]] does not represent an [[allergic reaction]] to the bite, but rather a [[skin infection]] with the [[Borrelia burgdorferi|Lyme bacteria]], [[Lyme disease microbiology|''Borrelia burgdorferi'' sensu lato]].
**EM resolves in approximately 28 days in untreated patients.<ref name="pmid6859726">{{cite journal| author=Steere AC, Bartenhagen NH, Craft JE, Hutchinson GJ, Newman JH, Rahn DW et al.| title=The early clinical manifestations of Lyme disease. | journal=Ann Intern Med | year= 1983 | volume= 99 | issue= 1 | pages= 76-82 | pmid=6859726 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6859726  }}</ref>
**EM resolves in approximately 28 days in untreated patients.<ref name="pmid6859726">{{cite journal| author=Steere AC, Bartenhagen NH, Craft JE, Hutchinson GJ, Newman JH, Rahn DW et al.| title=The early clinical manifestations of Lyme disease. | journal=Ann Intern Med | year= 1983 | volume= 99 | issue= 1 | pages= 76-82 | pmid=6859726 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6859726  }}</ref>
**The characteristic "bull's-eye" rash with central clearing is present in about 20% of [[endemic]] cases in the United States; whereas in Europe and the non-endemic United States 80% of [[rashes]] have central clearing. In [[endemic]] areas of the United States homogeneously red [[Rash|rashes]] are more frequent.<ref name="pmid11900494">{{cite journal| author=Smith RP, Schoen RT, Rahn DW, Sikand VK, Nowakowski J, Parenti DL et al.| title=Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. | journal=Ann Intern Med | year= 2002 | volume= 136 | issue= 6 | pages= 421-8 | pmid=11900494 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11900494  }} </ref><ref name="pmid11982300">{{cite journal| author=Edlow JA| title=Erythema migrans. | journal=Med Clin North Am | year= 2002 | volume= 86 | issue= 2 | pages= 239-60 | pmid=11982300 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11982300  }} </ref>
**The characteristic bullseye rash with central clearing is present in about 20% of [[endemic]] cases in the United States, whereas in Europe and the non-endemic United States, 80% of [[rashes]] have central clearing. In [[endemic]] areas of the United States, homogeneously red [[Rash|rashes]] are more frequent.<ref name="pmid11900494">{{cite journal| author=Smith RP, Schoen RT, Rahn DW, Sikand VK, Nowakowski J, Parenti DL et al.| title=Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. | journal=Ann Intern Med | year= 2002 | volume= 136 | issue= 6 | pages= 421-8 | pmid=11900494 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11900494  }} </ref><ref name="pmid11982300">{{cite journal| author=Edlow JA| title=Erythema migrans. | journal=Med Clin North Am | year= 2002 | volume= 86 | issue= 2 | pages= 239-60 | pmid=11982300 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11982300  }} </ref>
**[[Serological testing|Serologic testing]] is not recommended in patients with EM. Initially, majority of patients are [[seronegative]].<ref name="pmid17113969">{{cite journal| author=Feder HM, Abeles M, Bernstein M, Whitaker-Worth D, Grant-Kels JM| title=Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis. | journal=Clin Dermatol | year= 2006 | volume= 24 | issue= 6 | pages= 509-20 | pmid=17113969 | doi=10.1016/j.clindermatol.2006.07.012 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17113969  }} </ref>
**[[Serological testing|Serologic testing]] is not recommended in patients with EM. Initially, the majority of patients are [[seronegative]].<ref name="pmid17113969">{{cite journal| author=Feder HM, Abeles M, Bernstein M, Whitaker-Worth D, Grant-Kels JM| title=Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis. | journal=Clin Dermatol | year= 2006 | volume= 24 | issue= 6 | pages= 509-20 | pmid=17113969 | doi=10.1016/j.clindermatol.2006.07.012 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17113969  }} </ref>
**Multiple [[erythema migrans]] are present in [[disseminated disease]].<ref name="pmid158674072">{{cite journal| author=Wormser GP, McKenna D, Carlin J, Nadelman RB, Cavaliere LF, Holmgren D et al.| title=Brief communication: hematogenous dissemination in early Lyme disease. | journal=Ann Intern Med | year= 2005 | volume= 142 | issue= 9 | pages= 751-5 | pmid=15867407 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15867407  }}</ref>
**Multiple [[erythema migrans]] are present in [[disseminated disease]].<ref name="pmid158674072">{{cite journal| author=Wormser GP, McKenna D, Carlin J, Nadelman RB, Cavaliere LF, Holmgren D et al.| title=Brief communication: hematogenous dissemination in early Lyme disease. | journal=Ann Intern Med | year= 2005 | volume= 142 | issue= 9 | pages= 751-5 | pmid=15867407 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15867407  }}</ref>
**Mini [[erythema migrans]] - Sometimes , [[erythema migrans]] may be less than 5 cm in diameter. It is an important and atypical sign of early localized [[Lyme disease]].<ref name="pmid16484816">{{cite journal| author=Weber K, Wilske B| title=Mini erythema migrans--a sign of early Lyme borreliosis. | journal=Dermatology | year= 2006 | volume= 212 | issue= 2 | pages= 113-6 | pmid=16484816 | doi=10.1159/000090650 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16484816  }} </ref>
**Mini [[erythema migrans]]: sometimes, [[erythema migrans]] may be less than 5 cm in diameter. It is an important and atypical sign of early localized [[Lyme disease]].<ref name="pmid16484816">{{cite journal| author=Weber K, Wilske B| title=Mini erythema migrans--a sign of early Lyme borreliosis. | journal=Dermatology | year= 2006 | volume= 212 | issue= 2 | pages= 113-6 | pmid=16484816 | doi=10.1159/000090650 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16484816  }} </ref>
|
|
<gallery>
<gallery>




Image:Erythema chronicum migrans01.jpg|Erythema chronicum migrans <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/ Adapted from Dermatology Atlas.]''<ref name="Dermatology Atlas">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/}}</ref></SMALL></SMALL>
Image:Erythema chronicum migrans01.jpg|<small><small>Erythema chronicum migrans - [http://www.atlasdermatologico.com.br/disease.jsf?diseaseId=135 Source: Dermatology Atlas.]</small></small>


Image:Bullseye Lyme Disease Rash.jpg|Bulls eye lesion
Image:Bullseye Lyme Disease Rash.jpg|<small><small>Bulls eye lesion - [https://commons.wikimedia.org/wiki/File:Bullseye_Lyme_Disease_Rash.jpg Source: WIKICOMMONS]</small></small>


</gallery>
</gallery>
|}
|}
==Lyme Carditis==
==Lyme Carditis==
*[[Cardiac]] involvement occurs in about 5—10% of untreated [[Lyme disease]] and patients usually have symptoms related to fluctuating degrees of [[atrioventricular block]] ([[First degree AV block|first-degree block]] to [[complete heart block]]) including [[lightheadedness]], [[palpitations]], [[shortness of breath]], [[chest pain]], and [[syncope]].<ref name="pmid228688582">{{cite journal| author=Hu LT| title=In the clinic. Lyme disease. | journal=Ann Intern Med | year= 2012 | volume= 157 | issue= 3 | pages= ITC2-2 - ITC2-16 | pmid=22868858 | doi=10.7326/0003-4819-157-3-20120807-01002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22868858  }}</ref>  
*[[Cardiac]] involvement occurs in about 5-10% of untreated [[Lyme disease]] and patients usually have symptoms related to fluctuating degrees of [[atrioventricular block]] ([[First degree AV block|first-degree block]] to [[complete heart block]]) including [[lightheadedness]], [[palpitations]], [[shortness of breath]], [[chest pain]], and [[syncope]].<ref name="pmid228688582">{{cite journal| author=Hu LT| title=In the clinic. Lyme disease. | journal=Ann Intern Med | year= 2012 | volume= 157 | issue= 3 | pages= ITC2-2 - ITC2-16 | pmid=22868858 | doi=10.7326/0003-4819-157-3-20120807-01002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22868858  }}</ref>  
*Less commonly, patients may present with an acute picture of [[left ventricular dysfunction]], [[cardiomegaly]], [[perimyocarditis]], or pancarditis without noticeable [[cardiac murmurs]].<ref name="Steere1989">{{cite journal|last1=Steere|first1=Allen C.|title=Lyme Disease|journal=New England Journal of Medicine|volume=321|issue=9|year=1989|pages=586–596|issn=0028-4793|doi=10.1056/NEJM198908313210906}}</ref>
*Less commonly, patients may present with an acute picture of [[left ventricular dysfunction]], [[cardiomegaly]], [[perimyocarditis]], or pancarditis without noticeable [[cardiac murmurs]].<ref name="Steere1989">{{cite journal|last1=Steere|first1=Allen C.|title=Lyme Disease|journal=New England Journal of Medicine|volume=321|issue=9|year=1989|pages=586–596|issn=0028-4793|doi=10.1056/NEJM198908313210906}}</ref>
*Lyme [[carditis]] can occur independently, it is usually accompanied by other [[cutaneous]], [[joint]], or [[Neurology|neurologic]] features of [[Lyme disease]].<ref name="FishPride2008">{{cite journal|last1=Fish|first1=Airley E.|last2=Pride|first2=Yuri B.|last3=Pinto|first3=Duane S.|title=Lyme Carditis|journal=Infectious Disease Clinics of North America|volume=22|issue=2|year=2008|pages=275–288|issn=08915520|doi=10.1016/j.idc.2007.12.008}}</ref>
*Lyme [[carditis]] can occur independently, but it is usually accompanied by other [[cutaneous]], [[joint]], or [[Neurology|neurologic]] features of [[Lyme disease]].<ref name="FishPride2008">{{cite journal|last1=Fish|first1=Airley E.|last2=Pride|first2=Yuri B.|last3=Pinto|first3=Duane S.|title=Lyme Carditis|journal=Infectious Disease Clinics of North America|volume=22|issue=2|year=2008|pages=275–288|issn=08915520|doi=10.1016/j.idc.2007.12.008}}</ref>


==Lyme Arthritis==
==Lyme Arthritis==
*'''[[Lyme arthritis]]''' is the hallmark of [[Lyme disease history and symptoms#symptoms|stage 3 Lyme disease]].
*[[Lyme arthritis]] is the hallmark of [[Lyme disease history and symptoms#symptoms|stage 3 Lyme disease]].
*[[Lyme arthritis]] is most frequently presented symptom in [[Lyme disease history and symptoms#symptoms|late disseminated Lyme disease]].
*[[Lyme arthritis]] is most frequently presented symptom in [[Lyme disease history and symptoms#symptoms|late disseminated Lyme disease]].
*[[Lyme arthritis]] is not necessarily preceded by [[erythema migrans]].
*[[Lyme arthritis]] is not necessarily preceded by [[erythema migrans]].
*[[Lyme arthritis]] may occur due to hematogenous spread of ''[[Borrelia burgdorferi|B. burgdorferi]]'' to multiple joints during early [[infection]]. This might explain migratory [[arthralgia]] during early stage of [[Lyme disease]].
*[[Lyme arthritis]] may occur due to hematogenous spread of ''[[Borrelia burgdorferi|B. burgdorferi]]'' to multiple joints during early [[infection]]. This might explain migratory [[arthralgia]] during early stages of [[Lyme disease]].
*It usually takes months to years for [[Lyme disease]] to progress to [[Lyme arthritis]].
*It usually takes months to years for [[Lyme disease]] to progress to [[Lyme arthritis]].
*[[Lyme arthritis]] symptoms ranges from intermittent attack of [[monoarthritis]]/[[oligoarthritis]] to persistent [[arthritis]].
*[[Lyme arthritis]] symptoms range from intermittent attacks of [[monoarthritis]]/[[oligoarthritis]] to persistent [[arthritis]].
*Intermittent attack of [[Lyme arthritis]] ranges from 3 days to 11.5 months in duration with a mean of 3 months.<ref name="pmid36622852">{{cite journal| author=Steere AC, Schoen RT, Taylor E| title=The clinical evolution of Lyme arthritis. | journal=Ann Intern Med | year= 1987 | volume= 107 | issue= 5 | pages= 725-31 | pmid=3662285 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3662285  }}</ref>
*Intermittent attacks of [[Lyme arthritis]] range from 3 days to 11.5 months in duration with a mean of 3 months.<ref name="pmid36622852">{{cite journal| author=Steere AC, Schoen RT, Taylor E| title=The clinical evolution of Lyme arthritis. | journal=Ann Intern Med | year= 1987 | volume= 107 | issue= 5 | pages= 725-31 | pmid=3662285 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3662285  }}</ref>
*During early years of illness, attacks of [[Lyme arthritis]] are more frequent and longer  in duration. Both frequency and duration of attacks decreases subsequently.
*During early years of illness, attacks of [[Lyme arthritis]] are more frequent and longer  in duration. Both frequency and duration of attacks subsequently decrease.
* There may month or years of complete remission between each attack of [[Lyme arthritis]].
* There may months or years of complete remission between each attack of [[Lyme arthritis]].
*Majority of times [[Lyme arthritis]] involves large [[Joint|joints]]. Most commonly affected joint is [[Knee|knee joint]], but any joint can be affected including [[shoulder]], [[ankle]], [[elbow]], [[temporomandibular joint]], and [[wrist]].
*Most of the time, [[Lyme arthritis]] involves large [[Joint|joints]]. The most commonly affected joint is the [[Knee|knee joint]], but any joint can be affected including the [[shoulder]], [[ankle]], [[elbow]], [[temporomandibular joint]], and [[wrist]].
*[[Tendonitis]] and/or [[bursitis]] may also be present in few patients. Majority of times [[Joint|joints]] involved were [[shoulder]], [[knee]], or [[elbow]] .
*[[Tendonitis]] and/or [[bursitis]] may also be present in some patients. Most of the time, [[Joint|joints]] involved are the [[shoulder]], [[knee]], or [[elbow]].
*Majority of patients have little/no joint dysfunction after remission of attack. Few patients with persistent [[arthritis]] may show [[Erosion (dental)|erosion]] and permanent damage to [[joint]].<ref name="pmid3662285">{{cite journal| author=Steere AC, Schoen RT, Taylor E| title=The clinical evolution of Lyme arthritis. | journal=Ann Intern Med | year= 1987 | volume= 107 | issue= 5 | pages= 725-31 | pmid=3662285 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3662285  }} </ref>
*Most patients have little/no joint dysfunction after remission of attack. Some patients with persistent [[arthritis]] may show [[Erosion (dental)|erosion]] and permanent damage to [[joint]].<ref name="pmid3662285">{{cite journal| author=Steere AC, Schoen RT, Taylor E| title=The clinical evolution of Lyme arthritis. | journal=Ann Intern Med | year= 1987 | volume= 107 | issue= 5 | pages= 725-31 | pmid=3662285 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3662285  }} </ref>


==Manifestations of Lyme Disease by Stage==
==Manifestations of Lyme Disease by Stage==
Line 215: Line 214:
* [[Erythema migrans]]
* [[Erythema migrans]]
| valign="top" |
| valign="top" |
* Secondary annular lesions  
* Secondary annular [[lesions]]
* [[Malar rash]]
* [[Malar rash]]
* Diffuse [[erythema]] or [[urticaria]]  
* Diffuse [[erythema]] or [[urticaria]]  
* Evanescent lesions  
* Evanescent [[lesions]]
* Lymphocytoma
* Lymphocytoma
| valign="top" |
| valign="top" |
* [[Acrodermatitis chronica atrophicans]]  
* [[Acrodermatitis chronica atrophicans]]  
* Localized [[scleroderma]]-like lesions
* Localized [[scleroderma]]-like [[lesions]]
|-
|-
|''Musculoskeletal''
|''Musculoskeletal''
Line 274: Line 273:
* [[Iritis]]
* [[Iritis]]
* [[Choroiditis]]
* [[Choroiditis]]
* Retinal hemorrhage or [[retinal detachment]]
* Retinal [[hemorrhage]] or [[retinal detachment]]
* Panophthalmitis
* Panophthalmitis
| valign="top" |
| valign="top" |
Line 318: Line 317:
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}


[[Category:Bacterial diseases]]
[[Category:Bacterial diseases]]
Line 325: Line 327:
[[Category:Spirochaetes]]
[[Category:Spirochaetes]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Dermatology]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
[[Category:Dermatology]]
[[Category:Ophthalmology]]
 
[[Category:Neurology]]
{{WikiDoc Help Menu}}
[[Category:Cardiology]]
{{WikiDoc Sources}}
[[Category:Rheumatology]]

Latest revision as of 22:35, 29 July 2020

Lyme disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Epidemiology and Demographics

Causes

Differentiating Lyme disease from other Diseases

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

ECG

X-ray

CT scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Sudies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Lyme disease history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lyme disease history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lyme disease history and symptoms

CDC on Lyme disease history and symptoms

Lyme disease history and symptoms in the news

Blogs on Lyme disease history and symptoms

Directions to Hospitals Treating Lyme disease

Risk calculators and risk factors for Lyme disease history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2], Ilan Dock, B.S.

Overview

Lyme disease is divided into 3 stages and the symptoms are stage specific. Initial symptoms include bullseye rash called erythema migrans, with accompanying flu-like symptoms. Lyme disease can progress to cardiovascular, neurological, dermatological and/or musculoskeletal manifestations. Multiple erythema migrans develops as disease disseminates throughout the body. Most common neurological manifestation includes lymphocytic meningitis and cranial nerve palsies (usually facial nerve palsy). Dermatological manifestation includes borrelial lymphocytoma and acrodermatitis chronica atrophicans appearing in stage 2 and stage 3 Lyme disease respectively. Cardiac manifestation include Lyme carditis. Musculoskeletal manifestation include Lyme arthritis. There is a difference in clinical features of Lyme disease in patients living in different geographical regions depending on the genospecies of Borrelia burgdorferi sensu lato complex causing it.

History

  • The incubation period from infection to the onset of symptoms is usually 1–2 weeks, but can be much shorter (days), or much longer (months to years). Symptoms most often occur from May through September because the nymphal stage of the tick is responsible for most cases.[1] Asymptomatic infection can happen, but is uncommon.[2]
  • The specific areas of focus when obtaining patient history are outlined below:
    • Tick bite
    • Vacation, living, or working environment in endemic areas
    • Spending time outdoors (especially in woody or grassy areas)

Symptoms

Lyme disease is divided into 3 stages and symptoms are stage specific.

  • Stage 1 - Early localized disease
  • Stage 2 - Early disseminated disease
  • Stage 3 - Late disseminated disease

Stage 1 - Early localized disease

Features of early localized disease includes erythema migrans and flu-like symptoms.

Classic Lyme disease rash - Source: CDC.gov
Lyme disease, expanding rash with central clearing - Source: CDC.gov

Stage 2 - Early disseminate disease

Features of early disseminated disease can be divided by organ system and include:

Disseminated Lyme disease, multiple rash - Source: CDC.gov

Stage 3 - Late disseminated disease

Symptoms differentiated on the basis of frequency

[16]

Common symptoms Less common symptoms
Frequency of Lyme disease symptoms, 2001-2015 - Source: CDC.gov/
Difference in clinical features in Europe and North America[17]
Features Europe North America
Erythema migrans Single lesion more frequently Multiple lesions occurs more freuqently
Heterogenous dissemination Less common More common
Borrelial lymphocytoma Present Absent
Acrodermatitis chronica atrophicans Present Absent
Meningoradiculoneuritis More common Less common
Lyme arthritis Rarely preceded by erythema migrans Commonly preceded by erythema migrans

Erythema Migrans

Lyme Carditis

Lyme Arthritis

Manifestations of Lyme Disease by Stage

Manifestations of Lyme Disease by Stage[24]
System Stage 1 (Localized Infection) Stage 2 (Early Disseminated Infection) Stage 3 (Late Persistent Infection)
Skin
Musculoskeletal
Neurologic
Lymphatic
Heart
Eyes
Liver
Respiratory
Kidney
Genitourinary
Flu-like symptoms systems

Adapted from Steere AC. Lyme disease. N Engl J Med. 1989;321:586.

References

  1. Falco RC, McKenna DF, Daniels TJ, Nadelman RB, Nowakowski J, Fish D; et al. (1999). "Temporal relation between Ixodes scapularis abundance and risk for Lyme disease associated with erythema migrans". Am J Epidemiol. 149 (8): 771–6. PMID 10206627.
  2. Steere AC, Sikand VK, Schoen RT, Nowakowski J (2003). "Asymptomatic infection with Borrelia burgdorferi". Clin. Infect. Dis. 37 (4): 528–32. PMID 12905137.
  3. 3.0 3.1 Steere AC, Sikand VK (2003). "The presenting manifestations of Lyme disease and the outcomes of treatment". N Engl J Med. 348 (24): 2472–4. doi:10.1056/NEJM200306123482423. PMID 12802042.
  4. Nadelman RB, Nowakowski J, Forseter G, Goldberg NS, Bittker S, Cooper D; et al. (1996). "The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans". Am J Med. 100 (5): 502–8. PMID 8644761.
  5. 5.0 5.1 Wormser GP, McKenna D, Carlin J, Nadelman RB, Cavaliere LF, Holmgren D; et al. (2005). "Brief communication: hematogenous dissemination in early Lyme disease". Ann Intern Med. 142 (9): 751–5. PMID 15867407.
  6. Halperin JJ (2008). "Nervous system Lyme disease". Infect Dis Clin North Am. 22 (2): 261–74, vi. doi:10.1016/j.idc.2007.12.009. PMID 18452800.
  7. England JD, Bohm RP, Roberts ED, Philipp MT (1997). "Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease". Ann Neurol. 41 (3): 375–84. doi:10.1002/ana.410410313. PMID 9066359.
  8. Chabria SB, Lawrason J (2007). "Altered mental status, an unusual manifestation of early disseminated Lyme disease: A case report". 1 (1): 62. doi:10.1186/1752-1947-1-62. PMID 17688693.
  9. 9.0 9.1 Mullegger RR (2004). "Dermatological manifestations of Lyme borreliosis". Eur J Dermatol. 14 (5): 296–309. PMID 15358567.
  10. Stanek G, Strle F (2003). "Lyme borreliosis". Lancet. 362 (9396): 1639–47. doi:10.1016/S0140-6736(03)14798-8. PMID 14630446.
  11. Halperin JJ, Volkman DJ, Wu P (1991). "Central nervous system abnormalities in Lyme neuroborreliosis". Neurology. 41 (10): 1571–82. PMID 1922798.
  12. Rosenhall U, Hanner P, Kaijser B (1988). "Borrelia infection and vertigo". Acta Otolaryngol. 106 (1–2): 111–6. PMID 3421091.
  13. Moscatello AL, Worden DL, Nadelman RB, Wormser G, Lucente F (1991). "Otolaryngologic aspects of Lyme disease". Laryngoscope. 101 (6 Pt 1): 592–5. PMID 2041438.
  14. Logigian, Eric L.; Kaplan, Richard F.; Steere, Allen C. (1990). "Chronic Neurologic Manifestations of Lyme Disease". New England Journal of Medicine. 323 (21): 1438–1444. doi:10.1056/NEJM199011223232102. ISSN 0028-4793.
  15. Fallon BA, Nields JA (1994). "Lyme disease: a neuropsychiatric illness". The American journal of psychiatry. 151 (11): 1571–83. PMID 7943444.Hess A, Buchmann J, Zettl UK; et al. (1999). "Borrelia burgdorferi central nervous system infection presenting as an organic schizophrenialike disorder". Biol. Psychiatry. 45 (6): 795. PMID 10188012.)
  16. Ciesielski CA, Markowitz LE, Horsley R, Hightower AW, Russell H, Broome CV (1989). "Lyme disease surveillance in the United States, 1983-1986". Rev. Infect. Dis. 11 Suppl 6: S1435–41. PMID 2682955.
  17. Stanek G, Strle F (2008). "Lyme disease: European perspective". Infect Dis Clin North Am. 22 (2): 327–39, vii. doi:10.1016/j.idc.2008.01.001. PMID 18452805.
  18. 18.0 18.1 Feder HM, Abeles M, Bernstein M, Whitaker-Worth D, Grant-Kels JM (2006). "Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis". Clin Dermatol. 24 (6): 509–20. doi:10.1016/j.clindermatol.2006.07.012. PMID 17113969.
  19. Steere AC, Bartenhagen NH, Craft JE, Hutchinson GJ, Newman JH, Rahn DW; et al. (1983). "The early clinical manifestations of Lyme disease". Ann Intern Med. 99 (1): 76–82. PMID 6859726.
  20. Smith RP, Schoen RT, Rahn DW, Sikand VK, Nowakowski J, Parenti DL; et al. (2002). "Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans". Ann Intern Med. 136 (6): 421–8. PMID 11900494.
  21. Edlow JA (2002). "Erythema migrans". Med Clin North Am. 86 (2): 239–60. PMID 11982300.
  22. Weber K, Wilske B (2006). "Mini erythema migrans--a sign of early Lyme borreliosis". Dermatology. 212 (2): 113–6. doi:10.1159/000090650. PMID 16484816.
  23. Hu LT (2012). "In the clinic. Lyme disease". Ann Intern Med. 157 (3): ITC2-2–ITC2-16. doi:10.7326/0003-4819-157-3-20120807-01002. PMID 22868858.
  24. 24.0 24.1 Steere, Allen C. (1989). "Lyme Disease". New England Journal of Medicine. 321 (9): 586–596. doi:10.1056/NEJM198908313210906. ISSN 0028-4793.
  25. Fish, Airley E.; Pride, Yuri B.; Pinto, Duane S. (2008). "Lyme Carditis". Infectious Disease Clinics of North America. 22 (2): 275–288. doi:10.1016/j.idc.2007.12.008. ISSN 0891-5520.
  26. Steere AC, Schoen RT, Taylor E (1987). "The clinical evolution of Lyme arthritis". Ann Intern Med. 107 (5): 725–31. PMID 3662285.
  27. Steere AC, Schoen RT, Taylor E (1987). "The clinical evolution of Lyme arthritis". Ann Intern Med. 107 (5): 725–31. PMID 3662285.


Template:WikiDoc Sources